德纳维制药 DVAX 深 沪
等待开盘 09-18 09:30:00 美东时间
9.57
-0.130
-1.34%
华盛通- 最 高9.77
- 今 开9.75
- 成交量 197.58万股
- 最 低 9.53
- 昨 收 9.70
- 总市值 11.48亿
- 52周最高 14.63
- 市盈率 静 46.73
- 换手率 1.65%
- 52周最低 9.20
- 委 比 62.41%
- 总股本 1.20亿
- 历史最高 53.40
- 量 比 1.18
- 振 幅 2.47%
- 历史最低 1.80
- 每 手 1
- 风险率 1.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dynavax(DVAX.US)带状疱疹疫苗Ⅰ/Ⅱ期试验效果媲美葛兰素史克(GSK.US)Shingrix疫苗
Dynavax Technologies上涨约7%，此前该公司宣布，其在研带状疱疹疫苗Z-1018在Ⅰ/Ⅱ期试验中引发的免疫应答与葛兰素史克的Shingrix疫苗相当。
08-21 21:30
Dynavax Announces Positive Results for Shingles Vaccine
An announcement from Dynavax ( ($DVAX) ) is now available. On August 21, 2025, ...
08-21 20:43
Dynavax's Shingles Vaccine Candidate Z-1018 Shows Comparable Immune Response To Shingrix With Fewer Side Effects; Advancing To Next Trial Phase In 2025
At all doses and formulations evaluated in Part 1 of the trial, Z-1018 was well-tolerated and demonstrated a favorable tolerability profile, including lower solicited local and systemic post-injection reactions, versus
08-21 20:11
JMP Securities Maintains Market Outperform on Dynavax Technologies, Raises Price Target to $32
JMP Securities analyst Roy Buchanan maintains Dynavax Technologies (NASDAQ:DVAX) with a Market Outperform and raises the price target from $31 to $32.
08-08 23:35
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Earnings Preview: Travere Therapeutics
Travere Therapeutics (NASDAQ:TVTX) is gearing up to announce its quarterly earn...
08-06 03:10
Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting
EMERYVILLE, Calif., June 11, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) ("Dynavax" or the "Company"), a commercial-stage biopharmaceutical company developing and co...
06-11 23:01
Dynavax responds to proxy advisor calling for board change
Dynavax (NASDAQ:DVAX) said that a recommendation from proxy advisory firm Glass Lewis against two of its director nominees is wrong. "Significant Board composition and strategy changes have already be...
06-05 05:50
Dynavax Comments on Glass Lewis Recommendation
Dynavax is Already Delivering Significant Long Term Stockholder Value Through Execution of Current Strategy Overseen by Board; Deep Track's Inferior Short-Term Plan and Nominees are Not in t...
06-05 04:59
